Feb 012023
 
Drug Name
Active Ingredient(s)
Approval Date
FDA-Approved Use on Approval Date
Press Release
Drug Trials Snapshot
Orserdu elacestrant 1/27/2023 To treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated, advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy Drug Trials Snapshot
Jaypirca pirtobrutinib 1/27/2023 To treat relapsed or refractory mantle cell lymphoma in adults who have had at least two lines of systemic therapy, including a BTK inhibitor
Brenzavvy bexagliflozin 1/20/2023 To improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise Drug Trials Snapshot
Leqembi lecanemab-irmb 1/6/2023 To treat Alzheimer’s disease Press Release

Sorry, the comment form is closed at this time.